Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1981 Dec;12(6):761–770. doi: 10.1111/j.1365-2125.1981.tb01304.x

Measurement of the renal clearance of drugs.

G T Tucker
PMCID: PMC1401922  PMID: 7041933

Full text

PDF
761

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BORZELLECA J. F. DRUG MOVEMENT FROM THE ISOLATED URINARY BLADDER OF THE RABBIT. Arch Int Pharmacodyn Ther. 1965 Mar;154:40–50. [PubMed] [Google Scholar]
  2. Beckett A. H., Boyes R. N., Tucker G. R. Use of the analogue computer to predict the distribution and excretion of drugs under conditions of fluctuating urinary pH. J Pharm Pharmacol. 1968 Apr;20(4):277–282. doi: 10.1111/j.2042-7158.1968.tb09738.x. [DOI] [PubMed] [Google Scholar]
  3. Beckett A. H., Boyes R. N., Tucker G. T. Use of the analogue computer to examine the quantitative relation between urinary pH and kidney reabsorption of drugs partially ionized at physiological pH. J Pharm Pharmacol. 1968 Apr;20(4):269–276. doi: 10.1111/j.2042-7158.1968.tb09737.x. [DOI] [PubMed] [Google Scholar]
  4. Beckett A. H., Rowland M. Urinary excretion kinetics of amphetamine in man. J Pharm Pharmacol. 1965 Oct;17(10):628–639. doi: 10.1111/j.2042-7158.1965.tb07575.x. [DOI] [PubMed] [Google Scholar]
  5. Bekersky I., Colburn W. A., Fishman L., Kaplan S. A. Metabolism of salicylic acid in the isolated perfused rat kidney. Interconversion of salicyluric and salicyclic acids. Drug Metab Dispos. 1980 Sep-Oct;8(5):319–324. [PubMed] [Google Scholar]
  6. Bowman R. H. Renal secretion of [35-S]furosemide and depression by albumin binding. Am J Physiol. 1975 Jul;229(1):93–98. doi: 10.1152/ajplegacy.1975.229.1.93. [DOI] [PubMed] [Google Scholar]
  7. CONN R. B., SABO A. J., LANDES D., HO J. Y. INCONSTANCY OF RENAL CLEARANCE VALUES WITH CHANGING PLASMA CONCENTRATIONS. Nature. 1964 Jul 11;203:143–146. doi: 10.1038/203143a0. [DOI] [PubMed] [Google Scholar]
  8. Chiou W. L. Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma level--time curve. J Pharmacokinet Biopharm. 1978 Dec;6(6):539–546. doi: 10.1007/BF01062108. [DOI] [PubMed] [Google Scholar]
  9. Chremos A. N., Shen D., Gibaldi M., Proctor J. D., Newman J. H. Time-dependent change in renal clearance of bethanidine in humans. J Pharm Sci. 1976 Jan;65(1):140–142. doi: 10.1002/jps.2600650136. [DOI] [PubMed] [Google Scholar]
  10. Colburn W. A. Absorption of saccharin from rat urinary bladder. J Pharm Sci. 1978 Oct;67(10):1493–1494. doi: 10.1002/jps.2600671054. [DOI] [PubMed] [Google Scholar]
  11. Crooks J., O'Malley K., Stevenson I. H. Pharmacokinetics in the elderly. Clin Pharmacokinet. 1976;1(4):280–296. doi: 10.2165/00003088-197601040-00003. [DOI] [PubMed] [Google Scholar]
  12. Duchin K. L., Schrier R. W. Interrelationship between renal haemodynamics, drug kinetics and drug action. Clin Pharmacokinet. 1978 Jan-Feb;3(1):58–71. doi: 10.2165/00003088-197803010-00004. [DOI] [PubMed] [Google Scholar]
  13. Garrett E. R. Pharmacokinetics and clearances related to renal processes. Int J Clin Pharmacol Biopharm. 1978 Apr;16(4):155–172. [PubMed] [Google Scholar]
  14. HEATLEY N. G. Comparative serum concentration and excretion experiments with benzyl penicillin (G) and phenoxymethyl penicillin (V) on a single subject. Antibiotic Med Clin Ther (New York) 1956 Jan;2(1):33–41. [PubMed] [Google Scholar]
  15. Hinderling P. H., Garrett E. R., Wester R. D. Pharmacokinetics of beta-methyldigoxin in healthy humans I: intravenous studies. J Pharm Sci. 1977 Feb;66(2):242–253. doi: 10.1002/jps.2600660228. [DOI] [PubMed] [Google Scholar]
  16. Hogg M. I., Wiener P. C., Rosen M., Mapleson W. W. Urinary excretion and metabolism of pethidine and norpethidine in the newborn. Br J Anaesth. 1977 Sep;49(9):891–899. doi: 10.1093/bja/49.9.891. [DOI] [PubMed] [Google Scholar]
  17. Kamath B. L., Levy G. Letter: Renal contribution to drug biotransformation. J Pharm Sci. 1974 Aug;63(8):1342–1343. doi: 10.1002/jps.2600630851. [DOI] [PubMed] [Google Scholar]
  18. Kosaka Y., Takahashi T., Mark L. C. Intravenous thiobarbiturate anesthesia for cesarean section. Anesthesiology. 1969 Dec;31(6):489–506. doi: 10.1097/00000542-196912000-00001. [DOI] [PubMed] [Google Scholar]
  19. Kwan K. C., Till A. E. Novel method for bioavailability assessment. J Pharm Sci. 1973 Sep;62(9):1494–1497. doi: 10.1002/jps.2600620923. [DOI] [PubMed] [Google Scholar]
  20. Lalka D., Feldman H. Letter: Absolute drug bioavailability: approximation without comparison to parenteral dose for compounds exhibiting perturbable renal clearance. J Pharm Sci. 1974 Nov;63(11):1812–1812. doi: 10.1002/jps.2600631140. [DOI] [PubMed] [Google Scholar]
  21. Levy G. Effect of plasma protein binding on renal clearance of drugs. J Pharm Sci. 1980 Apr;69(4):482–483. doi: 10.1002/jps.2600690437. [DOI] [PubMed] [Google Scholar]
  22. Linton A. L., Luke R. G., Briggs J. D. Methods of forced diuresis and its application in barbiturate poisoning. Lancet. 1967 Aug 19;2(7512):377–379. doi: 10.1016/s0140-6736(67)92003-x. [DOI] [PubMed] [Google Scholar]
  23. MILNE M. D., SCRIBNER B. H., CRAWFORD M. A. Non-ionic diffusion and the excretion of weak acids and bases. Am J Med. 1958 May;24(5):709–729. doi: 10.1016/0002-9343(58)90376-0. [DOI] [PubMed] [Google Scholar]
  24. Martin B. K. Drug urinary excretion data--some aspects concerning the interpretation. Br J Pharmacol Chemother. 1967 Feb;29(2):181–193. doi: 10.1111/j.1476-5381.1967.tb01951.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Mason W. D., Kochak G., Winer N., Cohen I. Effect of exercise on renal clearance of atenolol. J Pharm Sci. 1980 Mar;69(3):344–345. doi: 10.1002/jps.2600690325. [DOI] [PubMed] [Google Scholar]
  26. Matsukura S., Sakamoto N., Takahashi K., Matsuyama H., Muranaka H. Effect of pH and urine flow on urinary nicotine excretion after smoking cigarettes. Clin Pharmacol Ther. 1979 May;25(5 Pt 1):549–554. doi: 10.1002/cpt1979255part1549. [DOI] [PubMed] [Google Scholar]
  27. Morselli P. L. Clincial pharmacokinetics in neonates. Clin Pharmacokinet. 1976;1(2):81–98. doi: 10.2165/00003088-197601020-00001. [DOI] [PubMed] [Google Scholar]
  28. Morselli P. L., Franco-Morselli R., Bossi L. Clinical pharmacokinetics in newborns and infants. Age-related differences and therapeutic implications. Clin Pharmacokinet. 1980 Nov-Dec;5(6):485–527. doi: 10.2165/00003088-198005060-00001. [DOI] [PubMed] [Google Scholar]
  29. Mudge G. H., Silva P., Stibitz G. R. Renal excretion by non-ionic diffusion: the nature of the disequilibrium. Med Clin North Am. 1975 May;59(3):681–698. doi: 10.1016/s0025-7125(16)32017-x. [DOI] [PubMed] [Google Scholar]
  30. Poust R. I., Mallinger A. G., Mallinger J., Himmelhoch J. M., Neil J. F., Hanin I. Absolute availability of lithium. J Pharm Sci. 1977 Apr;66(4):609–610. doi: 10.1002/jps.2600660447. [DOI] [PubMed] [Google Scholar]
  31. Rane A., Wilson J. T. Clinical pharmacokinetics in infants and children. Clin Pharmacokinet. 1976;1(1):2–24. doi: 10.2165/00003088-197601010-00002. [DOI] [PubMed] [Google Scholar]
  32. Reidenberg M. M. The binding of drugs to plasma proteins from patients with poor renal function. Clin Pharmacokinet. 1976;1(2):121–125. doi: 10.2165/00003088-197601020-00003. [DOI] [PubMed] [Google Scholar]
  33. Rose H. J., O'Malley K., Pruitt A. W. Depression of renal clearance of furosemide in man by azotemia. Clin Pharmacol Ther. 1977 Feb;21(2):141–146. doi: 10.1002/cpt1977212141. [DOI] [PubMed] [Google Scholar]
  34. Rose H. J., Pruitt A. W., McNay J. L. Effect of experimental azotemia on renal clearance of furosemide in the dog. J Pharmacol Exp Ther. 1976 Jan;196(1):238–247. [PubMed] [Google Scholar]
  35. Shen D., Gibaldi M., Israili A., Bellward G., Cunningham R., Throne M., Dayton P., McNay J. Pharmacokinetics of bethanidine in hypertensive patients. Clin Pharmacol Ther. 1975 Mar;17(3):363–373. doi: 10.1002/cpt1975173363. [DOI] [PubMed] [Google Scholar]
  36. Silas J. H., Lennard M. S., Tucker G. T., Smith A. J., Malcolm S. L., Marten T. R. The disposition of debrisoquine in hypertensive patients. Br J Clin Pharmacol. 1978 Jan;5(1):27–34. doi: 10.1111/j.1365-2125.1978.tb01594.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Steiness E. Renal tubular secretion of digoxin. Circulation. 1974 Jul;50(1):103–107. doi: 10.1161/01.cir.50.1.103. [DOI] [PubMed] [Google Scholar]
  38. Upton R. A., Buskin J. N., Williams R. L., Holford N. H., Riegelman S. Negligible excretion of unchanged ketoprofen, naproxen, and probenecid in urine. J Pharm Sci. 1980 Nov;69(11):1254–1257. doi: 10.1002/jps.2600691105. [DOI] [PubMed] [Google Scholar]
  39. WEINER I. M., GARLID K. D., ROMEO J. A., MUDGE G. H. Effects of tubular secretion and reabsorption on titration curves of tubular transport. Am J Physiol. 1961 Feb;200:393–399. doi: 10.1152/ajplegacy.1961.200.2.393. [DOI] [PubMed] [Google Scholar]
  40. WEINER I. M., MUDGE G. H. RENAL TUBULAR MECHANISMS FOR EXCRETION OF ORGANIC ACIDS AND BASES. Am J Med. 1964 May;36:743–762. doi: 10.1016/0002-9343(64)90183-4. [DOI] [PubMed] [Google Scholar]
  41. Wan S. H., Riegelman S. Renal contribution to overall metabolism of drugs. I. Conversion of benzoic acid to hippuric acid. J Pharm Sci. 1972 Aug;61(8):1278–1284. doi: 10.1002/jps.2600610822. [DOI] [PubMed] [Google Scholar]
  42. Wan S. H., Riegelman S. Renal contribution to overall metabolism of drugs. II. Biotransformation of salicylic acid to salicyluric acid. J Pharm Sci. 1972 Aug;61(8):1284–1287. doi: 10.1002/jps.2600610823. [DOI] [PubMed] [Google Scholar]
  43. Wan S. H., Von Lehmann B., Riegelman S. Renal contribution to overall metabolism of drugs. 3. Metabolism of p-aminobenzoic acid. J Pharm Sci. 1972 Aug;61(8):1288–1292. doi: 10.1002/jps.2600610824. [DOI] [PubMed] [Google Scholar]
  44. Yacobi A., Levy G. Effect of serum protein binding on sulfisoxazole distribution, metabolism, and excretion in rats. J Pharm Sci. 1979 Jun;68(6):742–746. doi: 10.1002/jps.2600680624. [DOI] [PubMed] [Google Scholar]
  45. von Lehmann B., Wan S. H., Riegelman S., Becker C. Renal contribution to overall metabolism of drugs. IV. Biotransformation of salicylic acid to salicyluric acid in man. J Pharm Sci. 1973 Sep;62(9):1483–1486. doi: 10.1002/jps.2600620920. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES